CEO of Dendeon Sold 202,090 shares, he's not confident about Dendreon!
Written by jack leeron
Apr 21, 2007 -- /prbuzz/ -- On April 2, 2007. The CEO of Dendreon Corporation sold 202,090 shares of his own company for $2,720,131 million dollars.
Why is he making this move? I think It usually is a sign that he's not confident that the FDA will approve the drug Provenge on May 15th. He's getting out fast. If a CEO of his own company selling more of his shares in the company and not acquiring more, it is a sign that tells me, he knows more anything else. Because of this information, I've bought so much Put options on this stock based on the lack of confidence of Mr. Mitchelle Gold.
Mr. Mitchelle Gold sold 202,090 shares of his own company because he knows that there isn't success with his company. He's pulling out fast. Take a look at the rock solid prove below.
Operating Margin: -35167.03%
Management Effectiveness:
Return on Assets: -30.55%
Return on Equity: -62.25%